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ABSTRACT
Objectives To investigate the perceptions, attitudes, 
behaviours and potential barriers to effective obesity 
care in the UK using data collected from people with 
obesity (PwO) and healthcare professionals (HCPs) in the 
Awareness, Care, and Treatment In Obesity maNagement–
International Observation (ACTION- IO) study.
Design UK’s PwO (body mass index of ≥30 kg/m2 based 
on self- reported height and weight) and HCPs who manage 
patients with obesity completed an online survey.
Results In the UK, 1500 PwO and 306 HCPs completed 
the survey. Among the 47% of PwO who discussed weight 
with an HCP in the past 5 years, it took a mean of 9 
years from the start of their struggles with weight until 
a discussion occurred. HCPs reported that PwO initiated 
35% of weight- related discussions; PwO reported that they 
initiated 47% of discussions. Most PwO (85%) assumed 
full responsibility for their own weight loss. The presence 
of obesity- related comorbidities was cited by 76% of 
HCPs as a top criterion for initiating weight management 
conversations. The perception of lack of interest (72%) 
and motivation (61%) in losing weight was reported as 
top reasons by HCPs for not discussing weight with a 
patient. Sixty- five per cent of PwO liked their HCP bringing 
up weight during appointments. PwO reported complex 
and varied emotions following a weight loss conversation 
with an HCP, including supported (36%), hopeful (31%), 
motivated (23%) and embarrassed (17%). Follow- up 
appointments were scheduled for 19% of PwO after a 
weight discussion despite 62% wanting follow- up.
Conclusions The current narrative around obesity 
requires a paradigm shift in the UK to address the delay 
between PwO struggling with their weight and discussing 
weight with their HCP. Perceptions of lack of patient 
interest and motivation in weight management must be 
challenged along with the blame culture of individual 
responsibility that is prevalent throughout society. While 
PwO may welcome weight- related conversations with an 
HCP, they evoke complex feelings, demonstrating the need 
for sensitivity and respect in these conversations.
Trial registration number NCT03584191.
BACKGROUND
The causes of obesity are complex and multi-
faceted, encompassing biological, genetic, 
environmental, economic, social and psycho-
logical factors.1–3 The chronic and relapsing 
nature of obesity is associated with many 
serious physical and psychological comor-
bidities, reduced quality of life and increased 
healthcare costs.2 4–8 The WHO has recognised 
obesity as a disease, and the National Institute 
for Health and Care Excellence provides guid-
ance on its assessment and treatment.9 More 
recently, it has been recognised as a risk factor 
for severity of COVID-19 infection.5 6 The 
prevalence of overweight and obesity among 
adults in the UK has been increasing and was 
63% in 2018.7 This increase is thought to be 
primarily caused by people’s latent biolog-
ical susceptibility interacting with a changing 
environment that includes more sedentary 
lifestyles and increased dietary abundance.1 
The prevalence of adiposity in the UK popu-
lation is approaching similar levels to those 
reported in the US (71%), Chile (74%) and 
Mexico (75%), which are among the highest 
recorded adult overweight and obesity levels 
in the world.8 The number of people with 
obesity (PwO) in the UK continues to rise, 
and severe and complex obesity (body mass 
index (BMI) ≥40 kg/m2) increased from less 
than 1% of the total population in 1993 to 
nearly 4% in 2017.10 The UK- wide National 
Health Service (NHS) costs attributable to 
overweight and obesity are projected to reach 
£9.7 billion by 2050, with wider societal costs 
Strengths and limitations of this study
 ► Strengths include the scientific rigour in the study 
design and implementation.
 ► The large number of UK respondents and the ability 
to directly compare the UK data to the equivalent 
global dataset is an additional strength.
 ► Limitations of this study include possible response 
bias from the population sampled and recall bias.
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estimated to reach £49.9 billion per year.11 The significant 
increase in the prevalence of obesity has not been matched 
by a proportionate expansion of continuing education on 
the biological basis and clinical management of obesity 
and training provision for healthcare professionals 
(HCPs), irrespective of their discipline.12 Moreover, little 
effort has been made to address weight stigma and soci-
etal effects of weight bias, which continue to be experi-
enced in a consistently negative way by those who have 
excess weight or obesity. Current evidence demonstrates 
that weight stigma is widespread in the UK,13 that weight 
stigma is experienced in many settings14 15 and that expe-
rience of stigma is associated with negative psychosocial 
outcomes, increased eating, reduced engagement with 
physical activity and weight gain.16
The variability of causal pathways of weight gain is inher-
ently unsuited to a ‘one size fits all’ treatment approach.1 
There is a range of existing guidance to support practice 
and care throughout the obesity care pathway in the UK.9 17 
However, the extent and range of the provision of weight 
management services is inconsistent and geographically 
dependent.18 The obesity care pathway has an important 
role within the whole systems approach to tackling obesity, 
as outlined in the Foresight’s report,1 and endorsed in the 
Department of Health and Social Care’s (DHSC) Call to 
Action19 and the Public Health England’s paper on a whole 
systems approach to obesity.20 The DHSC clinical policy 
outlines a tiered system of obesity care with a focus on 
public health and community advice in tier 1; primary care, 
community interventions and pharmacotherapy in tier 2; 
multi- disciplinary weight management service in tier 3 and 
secondary care and bariatric surgery in tier 4.21
Despite its wide global prevalence, obesity remains 
poorly understood by the general public and HCPs, and 
this contributes to the high levels of stigma associated with 
obesity.22 Society is continually informed through intense 
media coverage that obesity is simple and easily manipu-
lated.23 This attitude contributes to greater perceptions of 
individual responsibility, contrary to evidence that suggests 
that many factors outside a person’s control influence 
obesity.22 23 To improve the quality and accessibility of 
obesity care, a better understanding of the disease and the 
gaps between current and optimal obesity management 
strategies is required. The Awareness, Care, and Treat-
ment In Obesity maNagement–International Observation 
(ACTION- IO) study assessed the perceptions, attitudes 
and behaviours of PwO and HCPs.24 The global dataset24 
revealed a need to increase understanding of obesity and 
improve education concerning its aetiology. The aim of 
this subanalysis was to identify the perceptions, attitudes, 
behaviours and potential barriers to effective obesity care 
in the UK.
METHODS
Study design and participants
The ACTION- IO study was a cross- sectional, non- 
interventional study that collected data via an online 
survey in Australia, Chile, Israel, Italy, Japan, Mexico, 
Saudi Arabia, South Korea, Spain, the UK and the United 
Arab Emirates. The full methods for the ACTION- IO 
study have been reported previously.24 Eligible PwO 
in the UK were 18 years or older, with a current BMI 
of at least 30 kg/m2 based on self- reported height and 
weight. The PwO sample was targeted for demographic 
representativeness based on gender, age, income, race/
ethnicity and region. Therefore, PwO were excluded if 
they declined to provide any of these variables. Respon-
dents were also excluded for non- obesity reasons, for 
high BMI or for dramatic weight loss, that is, if they were 
pregnant, participated in intense fitness or body building 
programmes, or had significant, unintentional weight loss 
in the past 6 months. Eligible UK’s HCPs were in prac-
tice for 2 years or more, with at least 70% of their time 
spent in direct patient care, and who had seen 100 or 
more patients in the past month, at least 10 of whom had 
a BMI of at least 30 kg/m2. HCPs specialising in general, 
plastic or bariatric surgery were excluded. Respondents 
were recruited via online panel companies (via email) 
to whom they had given permission to be contacted for 
research purposes, and completed the survey in English. 
All respondents provided electronic informed consent 
prior to initiation of the screening questions and survey. 
Preceding participation, PwO were only informed of the 
purpose of the study, and were blinded to the specific 
study goals.
Survey development and procedures
The study was designed by an international steering 
committee of obesity experts (representing primary 
care, endocrinology and psychology, and including 
three medical doctors employed by Novo Nordisk), with 
support from KJT Group (Honeoye Falls, New York, 
USA), and based on the ACTION US and Canada ques-
tionnaires.25 26 KJT Group managed the acquisition and 
analysis of data; UK responses were collected between 
September 2018 and October 2018. Questionnaire items 
were carefully phrased and presented in identical order 
for each respondent. Items in a list were displayed in 
alphabetical, categorical, chronological or random order 
as relevant for each response. Respondents accessed the 
survey using a unique web link, details regarding the 
digital fingerprinting system used to assess unique site 
visitors has been previously described.24 To prevent dupli-
cate survey entries, unique site visitors were recorded via 
a user ID that was passed along the unique web link that 
respondents used to access the site. The system checked 
every respondent entering the survey against previous 
user IDs logged in its database. Respondents who began 
the survey and suspended were able to re- enter the survey 
while it was still open and finish the survey where they 
left off. Respondents who had already received a terminal 
status (complete, over- quota or terminate) were blocked 
from re- entering the survey. Following closure of the 
survey, no users were able to gain access. The user ID 
and data of suspended respondents were stored until the 
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Table 1 Sample demographics and characteristics
UK’s PwO (n=1500) HCPs (n=306)
Recruitment and qualification*
  Total survey invitations sent 69 676 2508
  Respondents 9786 886
  Respondents who completed screening questions 9779 737
  Respondents who qualified 2146 387
  Respondents who qualified and completed validated survey 1500 306
Age, years (range) 55.7 (19–88) 48.9 (28–68)
Gender, n (%)
  Male 687 (45.8%) 225 (73.5%)
  Female 811 (54.1%) 81 (26.5%)
  Other 2 (0.1%) –
BMI classification, n (%)
  Respondents† 1500 (100%) 236 (77.1%)
   Underweight or healthy range (<25 kg/m2) – 152 (64.4%)
   Overweight (25–29.9 kg/m2) – 72 (30.5%)
   Obesity Class I (30–34.9 kg/m2) 883 (56.2%) 7 (3.0%)
   Obesity Class II (35–39.9 kg/m2) 333 (22.4%) 2 (0.9%)
   Obesity Class III (≥40 kg/m2) 284 (21.4%) 3 (1.3%)
Number of comorbidities, n (%)
  0 264 (16.9%) –
  1 360 (25.0%) –
  2 330 (22.2%) –
  3 257 (16.0%) –
  ≥4 289 (20.0%) –
HCP category, n (%) 306 (100%)
  PCP – 156 (51.0%)
  SCP – 150 (49.1%)
   Endocrinologist – 43 (14.1%)
   Cardiologist – 51 (16.7%)
   Obstetrician–gynaecologist – 16 (5.2%)
   Other – 40 (13.1%)
Obesity specialist,‡ n (%)
  Yes – 162 (52.9%)
  No – 144 (47.1%)
All ‘n’ sizes for PwO are from unweighted data. Demographic percentages (age and gender) are also from unweighted data. 
All non- demographic percentage results are for PwO weighted data. HCP data were not weighted; therefore, n sizes and 
percentages are all unweighted data.
*Participation rate (those who completed the screener) was 99.9% for PwO and 84.7% for HCPs; completion rate was 100% 
for PwO and 85.8% for HCPs.
†Disclosure of height and weight was optional for HCPs. The percentages for the BMI categories were calculated using the 
number of respondents to this question as the denominator.
‡A physician who meets at least one of the following criteria: at least 50% of their patients are seen for obesity/weight 
management; or has advanced/formal training in treatment of obesity/weight management beyond medical school; or 
considers themselves to be an expert in obesity/weight loss management or works in an obesity service clinic.24
BMI, body mass index; HCP, healthcare professional; PCP, primary care professional; PwO, people with obesity; SCP, 
secondary care professional.
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survey was closed and were then eliminated from the data 
analysis. The study was conducted in accordance with the 
Guidelines for Good Pharmacoepidemiology Practices.27
To ensure representativeness to the general popula-
tion, the final PwO sample was weighted to demographic 
targets within each country for age, gender, income, race/
ethnicity and region. The HCP data were not weighted. 
Only data from those who completed the survey were 
included in the analyses.
Patient and public involvement
No patients or members of the public were involved in 
the design or conduct of the study. A patient represen-
tative was involved in the analysis and interpretation of 
the UK data and is an author on this article. She will also 




A total of 69 676 PwO and 2508 HCPs, in the UK, were 
invited. The response rate to the survey was 14% (9786/69 
676) for PwO and 35% (886/2508) for HCPs, as expected 
for this type of study and in line with the target sample 
size.24 Of those who completed the screening questions, 
the eligibility rate was 22% (2146/9779) for PwO and 
53% (387/737) for HCPs. The final UK sample for the 
ACTION- IO survey was 1500 PwO and 306 HCPs, of 
whom 156 were primary care professionals (PCPs) and 
150 were secondary care professionals (SCPs) (table 1). 
Some differences were observed in the survey outcomes 
between PCPs and SCPs, which will be reported in full at 
a later date.
Pre-consultation and initiation of weight management 
discussion
People with obesity
Only about half (47%) of all PwO had discussed excess 
weight or losing weight with an HCP in the past 5 years. 
It took a median of 6 years and mean of 9 years (range: 
0.0–56.0 years; IQR: 13 years) between the time when PwO 
said that they first started struggling with excess weight 
or obesity and when they first had a weight management 
conversation with an HCP (figure 1A). In comparison, 
globally it took a median of 3 years and a mean of 6 years 
(range: 0.0–68.0 years; IQR: 8 years (figure 1A)).24 Forty- 
seven per cent of PwO who discussed weight with an HCP 
reported that they initiated the conversation themselves. 
When PwO were asked to name the top five reasons why 
they may not discuss weight management with their HCP, 
the most common reason was the belief that it was their 
own responsibility to manage their weight (51% of PwO) 
(figure 1B). Indeed, when asked whether they agreed with 
the statement ‘my weight loss is completely my respon-
sibility’, 85% of PwO agreed with the statement. Thirty- 
four per cent of PwO said that they were motivated to lose 
weight, and 36% provided a neutral response (neither 
agreed nor disagreed that they were motivated). Only 
4% of PwO reported an indifference to losing weight as 
a reason for not discussing managing their weight with 
an HCP. Sixty- five per cent of PwO who previously had a 
weight conversation with their HCP liked that their HCP 
discussed their weight with them, and 58% who not previ-
ously had a conversation would have liked their HCP to 
bring up weight during their appointments. Most PwO 
(81%) believed that obesity has a large impact on overall 
health, similar to other chronic diseases such as diabetes 
(82%), stroke (88%), cancer (82%) or chronic obstruc-
tive pulmonary disease (COPD; 84%). The internet was 
cited as a source of information used by 31% of PwO for 
managing weight (figure 2A). Other sources of informa-
tion were reported as family and friends (27%), weight 
loss programmes (26%), information from an HCP 
(23%) and media (books/magazines: 21%, television 
programmes: 20%) (figure 2A).
Healthcare professionals
Those HCPs who discussed weight with their patients 
reported that 35% of the time the patient initiated the 
conversation. Compared with PwO (85%), a smaller 
proportion of HCPs (33%) placed the responsibility for 
weight loss on PwO. Only 13% of HCPs thought that their 
patients were motivated to lose weight, and 42% provided 
a neutral response (neither agreed nor disagreed that 
their patients were motivated). The most commonly 
selected reason for not discussing weight management 
with a patient (selected by 72% of HCPs) was the percep-
tion that the patient was not interested in losing weight, 
and 61% of HCPs selected lack of patient motivation 
(figure 1C). Other reasons provided for not discussing 
obesity with a patient were that the appointments were 
not long enough and that they felt rushed (selected by 
68% of HCPs), and that more important health issues/
concerns were an impediment to discussing obesity with 
a patient (selected by 58% of HCPs). In addition, almost 
one- third of HCPs (31%) reported that the good health 
of a patient and the absence of weight- related comor-
bidities would be a reason for not discussing weight 
management. The most important criterion for initiating 
weight management conversations with a patient was the 
presence of obesity- related comorbidities, cited by 76% 
of HCPs. Only 68% of the UK’s HCPs (vs 76% of global 
HCPs24) recognised the impact of obesity on health, and 
it was rated as less serious than diabetes, cancer, stroke 




Eighty- one per cent of the PwO who had discussed weight 
with an HCP had had a discussion with a PCP, 42% with 
a nurse, 18% with a dietitian/nutritionist and 17% with 
a diabetes educator. PwO reported a complex mixture 
of feelings following a weight loss conversation with an 
HCP (figure 2B). PwO cited a combination of feelings 
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such as supported 36%, hopeful 31%, motivated 23%, 
embarrassed 17%, indifferent 16%, discouraged 11%, 
relieved 10%, blamed 10%, rushed 10%, offended 4% 
and confused 4% (figure 2B).
Healthcare professionals
Fifty- nine per cent of HCPs reported that they were 
extremely or very comfortable discussing weight, 30% were 
neither comfortable nor uncomfortable and 11% were a 
little or not at all comfortable discussing weight. On average, 
HCPs reported that they spent 10 min interacting with their 
patients when discussing weight (range: 1–20 min).
Consultation outcomes and follow-up
People with obesity
Among the 47% of PwO who had discussed their weight 
with an HCP in the past 5 years, 49% reported that they had 
been diagnosed with obesity in the past by an HCP (24% 
of all PwO, figure 3). Only 19% of PwO who had discussed 
their weight with an HCP had a follow- up appointment 
scheduled (9% of all PwO) (figure 3). However, 62% of 
PwO would have liked a follow- up appointment and 96% 
reported attending or planning to attend a follow- up 
appointment if scheduled. The most frequent methods 
for managing weight tried by PwO were general improve-
ments in eating habits/reducing calories (reported by 
61% of PwO) and general increases in physical activity 
(55%), which were reported at a greater frequency than 
by global PwO (51% and 39% for general eating habits 
and physical activity, respectively; ACTION- IO study 
steering committee, personal communication). Bariatric 
surgery and behavioural therapy referral rates were 
reported in small numbers by the UK’s PwO (1% and 2%, 
respectively). Visits to a nutritionist/dietician and obesity 
specialist were reported less frequently by the UK’s PwO 
than global PwO (nutritionist/dietician: 11% UK, 24% 
global; obesity specialist: 2% UK, 9% global; ACTION- IO 
study steering committee, personal communication).
Healthcare professionals
On average, HCPs scheduled follow- up appointments with 
33% of their patients for obesity and 46% of HCPs said 
Figure 1 Number of years between when struggle with weight began and first discussed with an HCP and PwO/HCP reasons 
for not discussing weight management. (A) Approximate number of years reported by the UK and global PwO (ACTION- IO study 
steering committee, personal communication) between the beginning of their struggle with weight and first discussion with an 
HCP. Calculated at respondent level from questions, ‘Approximately how old were you when you first remember struggling with 
excess weight or obesity?’ and ‘Approximately how old were you when a healthcare provider first discussed your excess weight 
or recommended that you lose weight?’. (B) Reasons reported by the UK’s PwO for not discussing managing their weight 
with an HCP. (C) Reasons reported by the UK’s HCPs for not discussing weight management with their patients. ACTION- IO, 
Awareness, Care, and Treatment In Obesity maNagement–International Observation; HCP, healthcare professional; PwO, people 
with obesity.
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that patients kept these follow- up appointments always or 
most of the time. HCPs most frequently recommended 
general improvements in eating habits/reducing calo-
ries (reported by 61% of HCPs) and general increases 
in physical activity (65%). Referrals to obesity specialists 
were recommended less frequently by UK HCPs (12%) 
compared with the global dataset (23%).24
DISCUSSION
PwO are faced with biological predispositions, and 
societal and environmental conditions that contribute 
to obesity, weight stigma and discrimination. Obesity 
prevention and management are key health priorities and 
require a whole systems approach. However, the national 
response for obesity focuses on individual responsibility 
regarding nutrition and lack of physical activity. In this 
study, multiple barriers to effective weight management 
were identified, which are summarised in figure 4 and 
discussed below.
Initiation of weight management discussion with HCPs
Fewer than half of PwO in the UK (47%) had a discussion 
with an HCP about their weight in the past 5 years, despite 
HCPs being the gateway to weight management care in 
the NHS. Moreover, for the PwO who did have a weight 
discussion, it took a mean of 9 years after they first started 
struggling with their weight before having the discussion 
(compared with 6 years globally).24 This delay is particu-
larly important as it may create an opportunity for signif-
icant obesity- related complications to develop. This long 
delay may also reflect a higher degree of obesity stigma 
in the UK28 and a culture of individual responsibility for 
obesity.29 30 Indeed, a focus on individual responsibility is 
reflected in UK government policy on obesity.31 Reducing 
the time gap by initiating earlier weight management 
discussions may be an effective strategy for improving 
obesity treatment and preventing the development of 
comorbidities.
From the PwO perspective, a delay in seeking help 
could be linked to the high percentage (85%) of PwO 
who perceived their weight loss as completely their 
responsibility. From the HCP perspective, a delay in 
discussing obesity with a patient could be linked to 
reported perceptions that the patient was not interested 
or motivated in losing weight, consistent with previous 
research.32 33 Other impediments to the discussion were 
HCPs’ views that there were more important health 
issues to discuss and that a weight management discus-
sion is only required when weight- related comorbidities 
Figure 2 Sources of information and feelings after a weight discussion. (A) Sources of information most frequently used by 
the UK’s PwO for managing weight (reported by PwO). (B) Feelings reported by the UK’s PwO after their most recent weight or 
weight loss discussion with an HCP in the past 5 years. HCP, healthcare professional; PwO, people with obesity.
Figure 3 Obesity diagnoses and follow- up appointments 
with an HCP. Proportion of the UK’s PwO who discussed 
weight or weight loss with an HCP in the past 5 years and the 
frequency of obesity diagnoses and follow- up appointments. 
HCP, healthcare professional; PwO, people with obesity.
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are present, as supported by other studies.33 34 Moreover, 
HCPs in the UK underestimated the effect of obesity on 
health to a greater extent than the UK’s PwO and global 
HCPs.24 For PwO, this will likely require a change in the 
narrative around obesity to lessen focus on individual 
responsibility, and for HCPs a need to increase the under-
standing of the health consequences of obesity and the 
desire of PwO for help and support. The internet, media, 
and family and friends formed a substantial source of 
information for PwO for managing weight. We need to 
change this from personal responsibility to recognising 
the aetiology of obesity and its implications for PwO.
Consultation
Primary care is the gateway to obesity treatment, and most 
weight management discussions were held with a primary 
care physician or nurse. While many PwO welcomed 
weight discussions with HCPs, they also reported experi-
encing complex and varied emotions after these discus-
sions. It is important to acknowledge the complexity of 
the experience for PwO. Studies have previously reported 
patients feeling that their obesity had been ignored, 
dismissed, distorted or attributed as the explanation of all 
their health problems by HCPs.35–37 Negative experiences 
can contribute to depression, anxiety, low self- esteem and 
body dissatisfaction.38 39 Dissatisfactory conversations with 
an HCP may discourage PwO from seeking further weight 
management help in the future and reinforce feelings 
of personal responsibility for weight management. The 
attitudes of health professionals towards obesity and its 
management have been generally reported to be nega-
tive, and knowledge and skills in managing obesity have 
been noted to be inconsistent.40–45 Even well- intended 
acts can cause offence and humiliation,46 and PwO often 
experience their weight in profoundly negative ways as 
a result of the pervasive stigmatisation of obesity. Patient 
experiences are valid indications of the strengths and 
shortcomings of the services they receive.47 It is important 
to ensure that the narrative around obesity resonates with 
the lived experiences of those affected by it and encour-
ages patients to engage with an HCP.47 HCPs in turn 
should aim to provide compassionate care that is free of 
bias and use supportive communication and language to 
facilitate successful and meaningful conversations.47
HCPs often have limited time and resources, and 
lack of time has previously been reported as a barrier 
to discussing obesity.48 49 More HCPs in the UK (68%) 
than globally (54%) indicated that the limited appoint-
ment time would be a factor in not having a weight loss 
conversation.24 This may be a reflection of the average 
primary care consultation time in the UK, which is 
10 min and considerably shorter than in many other 
countries.50 51 Other potential barriers described in the 
literature have included uncertainty about appropriate 
language,48 concerns about compromising rapport9 and 
concerns discussing a potentially upsetting and stigma-
tising topic.22 50 52 However, in this study, relatively few 
HCPs reported discomfort with weight discussions.
Consultation outcomes and follow-up
Obesity diagnoses, follow- up appointments and referrals 
to specialists were infrequently reported by PwO, which 
could incorrectly reinforce the feeling of individual 
responsibility. Indeed, methods for managing weight 
reported by PwO, which relied largely on general improve-
ments in eating habits and physical activity, suggest a lack 
of knowledge of effective treatment methods and/or a 
consequence of the availability of therapeutic options 
(see below).
The data from HCPs on the frequency of follow- up 
appointments and methods for obesity management 
largely aligned with the data from PwO. Barriers to effective 
Figure 4 A conceptual model of the obesity treatment pathway and barriers to obesity care in the UK. BMI, body mass index; 
HCP, healthcare professional; PwO, people with obesity.
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weight management cited in the literature have included 
lack of effective and individualised treatment and/or 
referral options.40 41 50 53 Weight management services in 
the UK exist as part of fragmented health and social care 
systems, which are geographically dependent.49 54 55 The 
range of services and treatments, including pharmaco-
therapy and bariatric surgery, is limited in the UK, which 
may restrict HCPs in what they can offer patients. Indeed, 
HCPs report insufficient management options and scepti-
cism about their efficacy.56 57 This is further compounded 
by limited consultation times for the UK’s general practi-
tioners.50 51 The limited availability of weight management 
services, effective treatments and coherent, joined- up 
strategies in the UK health system are significant barriers 
to providing effective obesity care.55
Strengths and limitations
Strengths of this study include scientific rigour in the study 
design (including carefully phrased and ordered ques-
tions to prevent biased responses, blinded purpose of the 
survey for PwO and determination of eligibility by initial 
screening questions to eradicate bias during recruitment) 
and implementation (including stratified sampling to 
provide a representative cohort of the general population 
and rigorous data analysis). Other strengths include the 
large number of UK’s PwO and HCP respondents and the 
ability to directly compare the UK data to the equivalent 
global dataset. Limitations include the cross- sectional 
design and reliance on accurate reporting from the PwO 
and HCP respondents, which could be perceived as recall 
bias. The self- reported height and weight could under-
estimate the BMI of the PwO. A higher proportion of 
HCPs than might be expected self- identified as obesity 
specialists using the broad criteria specified in table 1. 
The low response rates could affect sample representa-
tiveness and is a known limitation for this type of study. 
Response bias from the population sampled cannot be 
ruled out. However, the PwO sample was representative of 
the demographics of the general population.
CONCLUSION
This study demonstrates the need to change the narra-
tive around obesity, with less stigmatising focus on 
individual responsibility, for the government, commis-
sioners, general public, PwO and HCPs. The findings 
identified areas that prevent PwO from seeking help 
and receiving appropriate care. In addition, the atti-
tudes of HCPs prevent them from offering the support 
PwO require for obesity management. The consultation 
about weight with an HCP is the gateway to treatment 
in the NHS and improving the frequency and quality 
of PwO–HCP conversations is essential. Sufficient 
time should be given to HCPs to approach the topic 
of overweight and obesity sensitively and effectively. 
The current survey did not have high numbers of 
people with a BMI of over 40 kg/m2; further research 
is required to understand whether people with higher 
BMIs have distinct experiences in the management of 
their obesity.
To conclude, a whole systems approach is required to 
address and eliminate weight bias and stigmatisation, 
to change the narrative around obesity in the UK, and 
to improve provision of NHS services. Educating the 
whole population, including PwO and HCPs, about the 
aetiology and psychology of obesity and the interaction 
with the obesogenic environment should help to ensure 
that patients access and receive quality care and effective 
weight treatment and management. Changing the narra-
tive around obesity will allow for a more effective delivery 
framework for health service providers and greater access 
to effective treatment pathways and weight management 
services for PwO.
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